Northeast Financial Consultants’s iShares US Medical Devices ETF IHI Stock Holding History

Northeast Financial Consultants’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$4.95M	Sell	79,059 -4,831	-6%	-$290K	0.2%	65
2025 Q1	$5.05M	Sell	83,890 -21,557	-20%	-$1.34M	0.22%	60
2024 Q4	$6.15M	Sell	105,447 -24,339	-19%	-$1.45M	0.26%	54
2024 Q3	$7.69M	Sell	129,786 -8,915	-6%	-$509K	0.34%	51
2024 Q2	$7.77M	Sell	138,701 -20,388	-13%	-$1.14M	0.36%	46
2024 Q1	$9.32M	Sell	159,089 -49,637	-24%	-$2.8M	0.46%	37
2023 Q4	$11.3M	Sell	208,726 -21,450	-9%	-$1.05M	0.62%	27
2023 Q3	$11.2M	Sell	230,176 -7,729	-3%	-$411K	0.7%	24
2023 Q2	$13.4M	Sell	237,905 -2,155	-0.9%	-$119K	0.82%	23
2023 Q1	$13M	Sell	240,060 -32,980	-12%	-$1.76M	0.83%	23
2022 Q4	$14.4M	Sell	273,040 -87,527	-24%	-$4.44M	0.97%	21
2022 Q3	$17M	Sell	360,567 -47,941	-12%	-$2.49M	1.25%	18
2022 Q2	$20.6M	Sell	408,508 -40,301	-9%	-$2.2M	1.44%	15
2022 Q1	$27.4M	Buy	448,809 +49,290	+12%	+$2.94M	1.58%	12
2021 Q4	$26.3M	Buy	399,519 +91,210	+30%	+$5.84M	1.59%	13
2021 Q3	$19.4M	Buy	308,309 +74,297	+32%	+$4.74M	1.29%	19
2021 Q2	$14.1M	Buy	234,012 +49,218	+27%	+$2.85M	0.95%	24
2021 Q1	$10.2M	Buy	184,794 +34,584	+23%	+$1.92M	0.78%	28
2020 Q4	$8.19M	Buy	150,210 +66,888	+80%	+$3.5M	0.68%	30
2020 Q3	$4.16M	Buy	83,322 +1,308	+2%	+$63.3K	0.38%	44
2020 Q2	$3.62M	Buy	82,014 +51,234	+166%	+$2.19M	0.35%	44
2020 Q1	$1.16M	Buy	30,780 +9,066	+42%	+$382K	0.13%	99
2019 Q4	$957K	Buy	21,714 +5,244	+32%	+$220K	0.09%	138
2019 Q3	$678K	Buy	16,470 +5,508	+50%	+$225K	0.07%	161
2019 Q2	$440K	Buy	10,962 +4,584	+72%	+$173K	0.05%	194
2019 Q1	$246K	Buy	+6,378	New	+$232K	0.03%	266

Other funds holding IHI

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Northeast Financial Consultants's IHI Position: Q2 2025 in Review

Northeast Financial Consultants reduced its iShares US Medical Devices ETF (IHI) stake by 5.8% in Q2 2025, selling an estimated $290K and leaving 79,059 shares worth $4.95M. The position accounts for 0.2% of the portfolio, ranked #65.

Northeast Financial Consultants first reported a position in IHI in Q1 2019 and has held it in 26 quarters since. The position peaked at $27.4M in Q1 2022. 546 funds tracked by Wall St. Rank hold IHI as of Q2 2025.

Northeast Financial Consultants held 79,059 shares of iShares US Medical Devices ETF worth $4.95M as of Q2 2025.
Northeast Financial Consultants sold 4,831 iShares US Medical Devices ETF shares in Q2 2025, an estimated $290K.
iShares US Medical Devices ETF made up 0.2% of Northeast Financial Consultants's portfolio in Q2 2025, its #65 holding.
Northeast Financial Consultants first reported a position in iShares US Medical Devices ETF in Q1 2019 and has held it in 26 quarters since.
Northeast Financial Consultants's iShares US Medical Devices ETF position peaked at $27.4M in Q1 2022.
546 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2025.

Based on Northeast Financial Consultants's 13F filing for Q2 2025, filed 15 Aug 2025.